Kodiak Sciences KOD
NASDAQ KOD
$35.36 -1.00 (-2.75%)
As of: Sep 4, 2026 · 3:59 PM EDT

Kodiak Sciences (KOD) Net Equity Issued and Repurchased (2018 - 2019)

Kodiak Sciences' (KOD) quarterly Net Equity Issued and Repurchased came in at $297.6 million in Q4 2019, up 255.53% YoY from $83.7 million in Q4 2018, and up 99100.0% on a QoQ basis from $300000.0 in Q3 2019.

Analysis

Kodiak Sciences (KOD) Net Equity Issued and Repurchased (2018 - 2019) Analysis & Trends

Kodiak Sciences (KOD) has 2 years of Net Equity Issued and Repurchased data on file, last reported at $297.6 million in Q4 2019.

  • Quarterly Net Equity Issued and Repurchased rose 255.53% year-over-year to $297.6 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $298.0 million (up 255.82% YoY) and the FY2020 annual result came in at $612.0 million, up 105.64% from the prior year.
  • Net Equity Issued and Repurchased rose to $297.6 million in Q4 2019, from $300000.0 in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $297.6 million in Q4 2019 to a low of $31000.0 in Q2 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 141.90 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Kodiak Sciences 2.21 Bn 2.21 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 297.60 Mn
Sep 30, 2019 300,000.00
Jun 30, 2019 31,000.00
Mar 31, 2019 83,000.00
Dec 31, 2018 83.71 Mn
Sep 30, 2018 49,000.00